Leading Growth Driver in the Anticoccidial Drugs Market in 2025: Impact Of Growing Demand For Meat Proteins In The Anticoccidial Drug Market Driver's Influence

What Are the Market Size and Growth Forecast for the Anticoccidial Drugs Market?
In recent times, there has been robust growth in the anticoccidial drugs market size. The market is expected to swell from $1.27 billion in 2024 to $1.37 billion in 2025, marking a compound annual growth rate (CAGR) of 7.6%. The historic growth is attributable to a worldwide surge in coccidiosis instances, amplified adoption of companion animals, a high occurrence rate of coccidiosis, economic implications, and heightened vigilance concerning food safety and animal health.

In the coming years, the anticoccidial drugs market is anticipated to exhibit robust growth, expanding to a market size of $1.81 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this growth in the forecast period include the increasing presence of veterinary healthcare, an escalating incidence of coccidiosis in animals, the rising usage of synthetic drugs, growing demand for feed additives, and an upswing in livestock production. The forecast period will also be marked by key trends such as a surge in demand due to emerging coccidiosis strains, a shift toward more natural and alternative treatment practices, more stringent regulatory examination leading to innovation, growing consumer inclination for poultry products free of antibiotics, advancements in drug delivery technologies, an increased emphasis on precautionary healthcare measures, and broader applications in the aquaculture and companion animal sectors.

What Are the Primary Growth Drivers for the Anticoccidial Drugs Market?
The anticoccidial drug market's progress is anticipated to be fuelled by the escalating demand for meat proteins. These proteins, inherently occurring in animal flesh, consist of various vital amino acids and contribute to numerous bodily activities. Factors like population surge, enhanced disposable income, urban expansion and a shift in dietary predilection towards protein-rich edibles increase the call for meat proteins. Being a crucial component in contemporary livestock rearing methods, anticoccidial drugs assure animal wellness and output, supporting farmers to efficiently and sustainably cater to the rising requirement of meat proteins. For illustration, the OECD report from July 2023 indicated that despite the predicted 2% rise in the global average per capita meat demand from the 2020-2022 base period to 2032, a 10% spike in the 2022 FAO meat price index was observed due to lean export supplies. Therefore, the escalating demand for meat proteins is fuelling the advancement of the anticoccidial drug market. Experiencing a surge, poultry farming is another factor expected to boost the anticoccidial drug market. It involves the breeding of domesticated avians, like chickens, turkeys, ducks and geese for meat, eggs and feathers production. Poultry farming is seeing growth due to the amplified call for protein, refined farming techniques, and the extension of global trade. To safeguard the birds from coccidiosis, particularly during the initial and most susceptible growth phases, anticoccidial drugs are often mixed with poultry feed or water. For example, the USDA Economic Research Service stated in June 2023 that the total sales for the poultry domain hit $76.9 billion in 2022, reflecting a 67% rise from the previous year. Hence, the thriving poultry farming sector is instrumental in the progression of the anticoccidial drug market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

Which Key Market Leaders Are Driving Anticoccidial Drugs Industry Growth?
Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

What Are the Emerging Trends in the Anticoccidial Drugs Industry?
Significant players in the anticoccidial drugs market are concentrating on the creation of innovative solutions like synthetic coccidiostats. These are engineered compounds aimed at minimizing resistance growth, enhancing efficacy, and tackling emerging problems in poultry and livestock management. They work by suppressing the proliferation and growth of coccidia parasites in animals. In an illustration from March 2023, Zoetis, an animal healthcare corporation based in the US, introduced Avi-Deccox. This is a reformulated synthetic coccidiostat created to manage coccidiosis in broiler chickens. Avi-Deccox specifically targets Eimeria acervulina and Eimeria tenella, pathogens that account for substantial economic loss in poultry farming. With decoquinate as its active ingredient (a trait it shares with its predecessor Deccox), Avi-Deccox tackles the rising issue of resistance associated with the regular use of ionophores in poultry farming by utilizing a different mechanism, delivering a more potent short-term knock-down effect.

What Are the Main Segments in the Anticoccidial Drugs Market?
The anticoccidial drugs market covered in this report is segmented -

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:
1) By Ionophore: Monensin, Lasalocid, Salinomycin
2) By Antibiotic: Tylosin, Lincomycin, Bacitracin
3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril, Clopidol
5) By Other Drug Classes: Amprolium, Robenidine

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Which Geographic Area Leads the Anticoccidial Drugs Market?
North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Anticoccidial Drugs Global Market Report?

- Market Size Analysis: Analyze the Anticoccidial Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Anticoccidial Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Anticoccidial Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Anticoccidial Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.